Skip to content
10-Q

Quarterly Report

GLOBAL IMMUNE TECHNOLOGIES INC.

0001144204-12-065426

← back to feed
Filed
Nov 29, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2012 · Nov 15, 2012 23.89M sh
Operating Cash Flow Q2 2012 · Sep 30, 2012 −$1.14M
Operating Cash Flow Q2 2012 · Sep 30, 2011 $0
Stockholders Equity Q2 2012 · Sep 30, 2012 −$993.15K
Current Liabilities Q2 2012 · Sep 30, 2012 $1M
Current Liabilities Q2 2012 · Mar 31, 2012 $915.44K
Current Assets Q2 2012 · Sep 30, 2012 $7.59K
Current Assets Q2 2012 · Mar 31, 2012 $0
Total Assets Q2 2012 · Sep 30, 2012 $7.59K
Total Assets Q2 2012 · Mar 31, 2012 $0
Sga Expense Q2 2012 · Sep 30, 2012 $337.51K
Sga Expense Q2 2012 · Sep 30, 2011 $0
Sga Expense Q2 2012 · Sep 30, 2011 $0
Net Income Q2 2012 · Sep 30, 2012 −$2.49M
Net Income Q2 2012 · Sep 30, 2011 −$7.5K
Net Income Q2 2012 · Sep 30, 2011 −$15K
Operating Income Q2 2012 · Sep 30, 2012 −$1.57M
Operating Income Q2 2012 · Sep 30, 2011 −$7.5K
Operating Income Q2 2012 · Sep 30, 2011 −$15K
Cash And Equivalents Q2 2012 · Sep 30, 2011 $0
Cash And Equivalents Q2 2012 · Mar 31, 2011 $0